PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRY.MI vs. EW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PRY.MI and EW is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

PRY.MI vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Prysmian SpA (PRY.MI) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
3.88%
3.41%
PRY.MI
EW

Key characteristics

Sharpe Ratio

PRY.MI:

1.92

EW:

-0.38

Sortino Ratio

PRY.MI:

2.33

EW:

-0.21

Omega Ratio

PRY.MI:

1.33

EW:

0.96

Calmar Ratio

PRY.MI:

4.38

EW:

-0.29

Martin Ratio

PRY.MI:

10.49

EW:

-0.73

Ulcer Index

PRY.MI:

5.34%

EW:

21.43%

Daily Std Dev

PRY.MI:

29.20%

EW:

40.81%

Max Drawdown

PRY.MI:

-70.43%

EW:

-54.32%

Current Drawdown

PRY.MI:

-4.58%

EW:

-43.91%

Fundamentals

Market Cap

PRY.MI:

€19.92B

EW:

$43.23B

EPS

PRY.MI:

€1.87

EW:

$2.34

PE Ratio

PRY.MI:

36.74

EW:

31.32

PEG Ratio

PRY.MI:

1.59

EW:

5.83

Total Revenue (TTM)

PRY.MI:

€12.36B

EW:

$4.34B

Gross Profit (TTM)

PRY.MI:

€4.62B

EW:

$3.39B

Returns By Period

In the year-to-date period, PRY.MI achieves a 11.42% return, which is significantly higher than EW's -0.99% return. Over the past 10 years, PRY.MI has outperformed EW with an annualized return of 17.26%, while EW has yielded a comparatively lower 12.65% annualized return.


PRY.MI

YTD

11.42%

1M

-4.29%

6M

11.17%

1Y

54.03%

5Y*

27.24%

10Y*

17.26%

EW

YTD

-0.99%

1M

6.34%

6M

3.41%

1Y

-16.46%

5Y*

-0.57%

10Y*

12.65%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRY.MI vs. EW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRY.MI
The Risk-Adjusted Performance Rank of PRY.MI is 9191
Overall Rank
The Sharpe Ratio Rank of PRY.MI is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of PRY.MI is 8585
Sortino Ratio Rank
The Omega Ratio Rank of PRY.MI is 8686
Omega Ratio Rank
The Calmar Ratio Rank of PRY.MI is 9797
Calmar Ratio Rank
The Martin Ratio Rank of PRY.MI is 9292
Martin Ratio Rank

EW
The Risk-Adjusted Performance Rank of EW is 2828
Overall Rank
The Sharpe Ratio Rank of EW is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 2727
Sortino Ratio Rank
The Omega Ratio Rank of EW is 2424
Omega Ratio Rank
The Calmar Ratio Rank of EW is 3030
Calmar Ratio Rank
The Martin Ratio Rank of EW is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PRY.MI vs. EW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Prysmian SpA (PRY.MI) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PRY.MI, currently valued at 1.56, compared to the broader market-2.000.002.001.56-0.34
The chart of Sortino ratio for PRY.MI, currently valued at 1.98, compared to the broader market-4.00-2.000.002.004.006.001.98-0.16
The chart of Omega ratio for PRY.MI, currently valued at 1.28, compared to the broader market0.501.001.502.001.280.97
The chart of Calmar ratio for PRY.MI, currently valued at 3.10, compared to the broader market0.002.004.006.003.10-0.26
The chart of Martin ratio for PRY.MI, currently valued at 6.92, compared to the broader market-10.000.0010.0020.0030.006.92-0.64
PRY.MI
EW

The current PRY.MI Sharpe Ratio is 1.92, which is higher than the EW Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of PRY.MI and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.56
-0.34
PRY.MI
EW

Dividends

PRY.MI vs. EW - Dividend Comparison

PRY.MI's dividend yield for the trailing twelve months is around 1.02%, while EW has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
PRY.MI
Prysmian SpA
1.02%1.14%1.46%1.59%1.51%0.86%4.00%2.46%1.58%1.72%2.07%2.77%
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

PRY.MI vs. EW - Drawdown Comparison

The maximum PRY.MI drawdown since its inception was -70.43%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for PRY.MI and EW. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-4.90%
-43.91%
PRY.MI
EW

Volatility

PRY.MI vs. EW - Volatility Comparison

Prysmian SpA (PRY.MI) has a higher volatility of 13.12% compared to Edwards Lifesciences Corporation (EW) at 9.87%. This indicates that PRY.MI's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
13.12%
9.87%
PRY.MI
EW

Financials

PRY.MI vs. EW - Financials Comparison

This section allows you to compare key financial metrics between Prysmian SpA and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. PRY.MI values in EUR, EW values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab